Amino Innovations Forms Strategic Research Partnership with University of Alberta Scientists to Advance Peptide Innovation

Executive Summary

• Pangea Natural Foods’ wholly‑owned subsidiary Amino Innovations has entered a research services agreement with Dr. Neal Davies and Dr. Raimar Loebenberg of the University of Alberta to develop non‑injectable peptide delivery systems.
• The collaboration will use the university’s Drug Development and Innovation Centre facilities to conduct in‑vitro, ex‑vivo and in‑silico studies on peptides such as BPC‑157, GHK‑Cu and KPV, employing natural permeation enhancers.
• Results are expected to expand Amino Innovations’ intellectual property portfolio, improve regulatory credibility and accelerate product development for nutraceutical and cosmeceutical markets.

Key Details

• Parties Involved: Amino Innovations (subsidiary of Pangea Natural Foods) – Dr. Neal Davies & Dr. Raimar Loebenberg (senior professors, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta).
• Agreement Type: Research Services Agreement granting access to the University’s Drug Development and Innovation Centre (DDIC) facilities, personnel and testing platforms.
• Research Scope:
• Pharmacokinetic (PK) & pharmacodynamic (PD) modeling for formulation optimization.
• Permeation and dissolution testing using skin/tissue membrane models.
• Formulation refinement with natural excipients (e.g., Tremella fuciformis, DMSO).
• Stability and analytical testing of peptide products.
• Target Peptides: BPC‑157, GHK‑Cu, KPV.
• Intended Outcomes: Strengthen Amino Innovations’ IP portfolio, enhance regulatory credibility, accelerate new product development in nutraceutical and cosmeceutical markets.
• Quotes:
• Dr. Neal Davies & Dr. Raimar Loebenberg – expressed enthusiasm for collaborating on evidence‑based peptide innovation.
• Justin Kirkland, CSO & Co‑Founder of Amino Innovations – highlighted access to leading research expertise and infrastructure.
• Pratap Sandhu, CEO of Pangea – emphasized commitment to science‑driven wellness innovation and long‑term growth.

Notable Quotes

• “We are thrilled to work with Amino Innovations, a company that is focused on evidence‑based, non‑injectable natural peptide innovation.” – Dr. Neal Davies & Dr. Raimar Loebenberg
• “This partnership gives us access to leading research expertise and infrastructure… creating a level of scientific transparency within the wellness industry.” – Justin Kirkland, CSO, Amino Innovations
• “We are excited to support Amino Innovations as it continues to lead in science‑driven wellness innovation… reinforces our commitment to developing credible, research‑backed products.” – Pratap Sandhu, CEO, Pangea

Materiality Assessment: Non‑Material – Positive (the partnership is a forward‑looking initiative that may enhance future growth but does not yet constitute a material financial event).